$1.68
-0.12-6.67%
最終更新: Oct 16, 4:23 PM
$1.69
-0.11-6.11%
Benzinga
Benzinga
Benzinga
日曜日, 10 18
Benzinga
© 2026 Benzinga | All Rights Reserved
Pyxis Oncology (PYXS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.35 | $-0.35 | $-0.34 | $-0.35 |
| Actual | $-0.40 | $-0.37 | $-0.29 | $-0.35 |
| Surprise | -14.3% | -5.71% | +14.7% | 0.00% |
| Revenue | ||||
| Estimate | $22220 | — | — | — |
| Actual | $0 | $0 | $11.0M | $0 |
| Surprise | -100.0% | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.28 | $-0.26 | $-0.25 | $-0.25 |
| Revenue | ||||
| Consensus | — | $19440 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.40 | $-0.35 | -14.3 % |
| Q1 | May 14, 2026 | $-0.37 | $-0.35 | -5.71 % |
| Q4 | Mar 23, 2026 | $-0.29 | $-0.34 | 14.7 % |
| Q3 | Nov 3, 2025 | $-0.35 | $-0.35 | 0.00 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $0 | $22.22K | -100.0 % |
| Q1 | May 14, 2024 | $16.15M | $4.12M | 291.9 % |
| Q4 | Mar 21, 2024 | $0 | $170.00K | -100.0 % |